TOSOH BIOSCIENCE

Tosoh Bioscience, a division of Tosoh Corporation (established 1935, Tokyo Stock Exchange listed), is a global provider of clinical diagnostic analyzers and separation & purification chromatography solutions. The Clinical Diagnostics division serves clinical laboratories, hospitals, and healthcare systems with immunoassay testing platforms and assays spanning oncology, diabetes, fertility, and endocrinology applications. The Separation & Purification division supplies liquid chromatography systems and consumables for biopharma, biotech, chemical, and research industries, with specializations in antibody analysis, biomolecule separation, oligonucleotide purification, and polymer characterization. Key product lines include the AIA-2000 high-throughput immunoassay analyzer, AIA-900 with automated sample handling, SkillPak pre-packed chromatography columns, and LenS3 MALS detector systems. The company operates manufacturing and service capabilities across multiple regions (US, Europe, Japan, China, India, Asia-Pacific) and supports bioprocess development, analytical testing, and research applications. Tosoh maintains a global workforce of over 14,000 across 100+ companies and serves principal markets in chemicals, bioscience, automotive, consumer electronics, and environmental sectors.